Home > Financial Ratios > TATVA CHINTAN PHARMA CHEM

TATVA CHINTAN PHARMA CHEM
Core EBITDA Growth

    Back to All Ratios
TATVA CHINTAN PHARMA CHEM is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for TATVA CHINTAN PHARMA CHEM
Please provide your vote to see the results

TATVA CHINTAN PHARMA CHEM Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 163.93-51.5814.10-43.4063.52

What is the latest Core EBITDA Growth ratio of TATVA CHINTAN PHARMA CHEM ?

The latest Core EBITDA Growth ratio of TATVA CHINTAN PHARMA CHEM is 163.93 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar2026163.93
Mar2025-51.58
Mar202414.10
Mar2023-43.40
Mar202263.52

How is Core EBITDA Growth of TATVA CHINTAN PHARMA CHEM Trending?

Years Core EBITDA Growth % Change
Mar2026 163.93
Positive
Mar2025 -51.58
Negative
Mar2024 14.1
Positive
Mar2023 -43.4
Negative
Mar2022 63.52 -

Other Financial Ratios of TATVA CHINTAN PHARMA CHEM


Compare Core EBITDA Growth ratio of peers of TATVA CHINTAN PHARMA CHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TATVA CHINTAN PHARMA CHEM ₹3,946.3 Cr 3.8% -5.4% 58.4% Stock Analytics
SOLAR INDUSTRIES INDIA ₹201,838.0 Cr 9.4% 19.7% 53.2% Stock Analytics
PIDILITE INDUSTRIES ₹160,062.0 Cr -2.9% -4.3% 1.9% Stock Analytics
SRF ₹74,550.8 Cr -2.7% -3.2% -13.9% Stock Analytics
GUJARAT FLUOROCHEMICALS ₹52,220.5 Cr -1.1% 4.4% 33.9% Stock Analytics
GODREJ INDUSTRIES ₹38,146.7 Cr 0.5% -11.5% -3.4% Stock Analytics


TATVA CHINTAN PHARMA CHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TATVA CHINTAN PHARMA CHEM

3.8%

-5.4%

58.4%

SENSEX

-2.4%

-4.8%

-7.2%


You may also like the below Video Courses